Bioviratech (BVT)

Bioviratech (BVT)

Healthcare

1 BVT = 1 USD

Bioviratech is a legal obligation, a promise by a pharmaceutical company to embrace a more even distribution of vaccines. Bioviratech creates options for future vaccines using smart contracts. Combining the pharmaceutical distribution of vaccines, Crypto and blockchain.

Start:

Sep 26, 2022 00:00:00

Ended:

Oct 25, 2022 00:00:00

0 Likes 0 Dislikes

ICO Details

ICO Details
View Details such as General, Token Supply & More
Bioviratech (BVT) Token Sale Details
Ticker Symbol:

BVT

Blockchain Network:

Binance Smart Chain

Token Type:

BEP-20

Category:

Healthcare

ICO Token Sale Price:

1 BVT = 1 USD

Accept Payments:

BNB, ETH, USDT, Mastercard, VISA

Launchpad:

Updating

Rating:

Token Metrics & Distribution
Total Supply:

360,000,000 BVT

Pre Sale:

18,000 BVT

Public Sale:

72,000,000 BVT

Insiders:

3,600,000 BVT

Team:

46,728,000 BVT

Partners:

54,000,000 BVT

Reserves:

18,000,000 BVT

Airdrop:

126,000,000 BVT

Rewards:

54,000 BVT

Bounty:

3,600,000 BVT

Others:

36,000,000 BVT

Pre Sale 0.01%
Public Sale 20.00%
Insiders 1.00%
Team 12.98%
Partners 15.00%
Reserves 5.00%
Airdrop 35.00%
Rewards 0.02%
Bounty 1.00%
Others 10.00%
Token Sale Price
Social Media
About Bioviratech (BVT)

What is Bioviratech (BVT)?

The genesis of Bioviratech was founded during the COVID pandemic and the distribution of vaccines. Bioviratech believes that vaccines should be more widely available, regardless of geographical location, political power, or religious orientation. That this is an optic that the pharmaceutical companies would rather avoid without discriminating against their shareholders and that individuals who display forward thinking should be given the opportunity to fast track past possible distribution issues of a future pandemic, after the most vulnerable have been vaccinated.

Bioviratech combines the world of the pharmaceutical distribution of vaccines, international law, smart contracts/ Crypto and blockchain to generate legal contracts linked to unique smart contracts. These create tokenised options that give the bearer the right to, but not the cost of, a vaccine for a future pandemic after the most vulnerable have been vaccinated.

Bioviratech is a legal obligation, a promise by a pharmaceutical company to embrace a more even distribution of vaccines. Bioviratech creates options for future vaccines using smart contracts. Combining the pharmaceutical distribution of vaccines, Crypto and blockchain.

Bioviratech (BVT) Unique Features

Updating…

Roadmap

Bioviratech (BVT) Token Economy

Our mission is to create legally binding contracts, that offer the token holder the option of primary access to a vaccine, of a possible future pandemic. Which will probably occur. The challenge is to counteract the possible token rise in value, making it tempting for those in emerging nations, to sell their airdropped tokens or become unaffordable as time passes.

Our solution is to offer two tokens. One called Bioviratech (BVT) which is speculative, and one called Bioviratech USD (BVTD) which is pegged to ¼ of a $1.00 via Fiat Collateralization. Stabilising the token, to some extent. Both tokens have the underlying legal contract attached to their smart contacts but behave differently on the open market. The only weakness is OTC, over-the-counter transactions, but that is also one of strengths of smart contracts.

Detailed Token Metrics

Token Distribution

Bioviratech (BVT) 45% of the legal contracts – Speculative

Bioviratech USD (BVTD) 55% of the legal contracts – Fiat collateralized stable token pegged to ¼ of $1.00 USD

Each token is one unit and indivisible i.e 1 decimal

Token Release Schedule

Partners & Advisors

Updating…

Team Members

Terence Harte: Founder, CEO

Investors

Updating…